NASDAQ:CRME, TSX: COM VANCOUVER, April 26, 2018 /CNW/ - Cardiome Pharma Corp. (NASDAQ:CRME /TSX: COM ), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mr. David Dean, Chief Business Development Officer of Cardiome, will present at the Bloom Burton & Co. Healthcare Investor Conference. The presentation will take place at the Sheraton Centre Hotel Toronto on Wednesday, May 2, 2018 at 11:30 a.m. EST in Toronto, Canada. About Cardiome Pharma Corp. Cardiome Pharma Corp. is a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients.